Kelly E. Manning

1000 total citations
10 papers, 165 citations indexed

About

Kelly E. Manning is a scholar working on Infectious Diseases, Clinical Biochemistry and Surgery. According to data from OpenAlex, Kelly E. Manning has authored 10 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Clinical Biochemistry and 1 paper in Surgery. Recurrent topics in Kelly E. Manning's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Kelly E. Manning is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Kelly E. Manning collaborates with scholars based in United States and Canada. Kelly E. Manning's co-authors include Daniel Singer, Sally Young, R. Baker, William R. Jarvis, Elise M. Jochimsen, Robert L. Baker, Mehul S. Suthar, Grace Mantus, Evan J. Anderson and Shailen N. Banerjee and has published in prestigious journals such as Journal of Virology, American Journal Of Pathology and Infection Control and Hospital Epidemiology.

In The Last Decade

Kelly E. Manning

8 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly E. Manning United States 6 134 57 26 19 15 10 165
Orna Schwartz Israel 8 84 0.6× 32 0.6× 55 2.1× 20 1.1× 5 0.3× 21 175
Samia Arshad United States 9 134 1.0× 46 0.8× 118 4.5× 21 1.1× 7 0.5× 16 219
Femke Mollema Netherlands 5 174 1.3× 83 1.5× 52 2.0× 41 2.2× 6 0.4× 10 209
Laura Campogiani Italy 9 95 0.7× 16 0.3× 69 2.7× 25 1.3× 17 1.1× 32 222
Zeynep Türe Türkiye 8 105 0.8× 15 0.3× 67 2.6× 30 1.6× 9 0.6× 50 220
Akitoshi Ueno Japan 9 243 1.8× 23 0.4× 44 1.7× 15 0.8× 12 0.8× 20 284
Carmen Gómez-González Spain 6 142 1.1× 79 1.4× 40 1.5× 37 1.9× 6 0.4× 17 191
E. Ruiz de Gopegui Spain 9 147 1.1× 74 1.3× 95 3.7× 28 1.5× 10 0.7× 12 202
E.P.M. van Elzakker Netherlands 6 121 0.9× 68 1.2× 68 2.6× 30 1.6× 5 0.3× 11 182
Rafaël Mahieu France 8 38 0.3× 24 0.4× 37 1.4× 19 1.0× 7 0.5× 31 180

Countries citing papers authored by Kelly E. Manning

Since Specialization
Citations

This map shows the geographic impact of Kelly E. Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Manning more than expected).

Fields of papers citing papers by Kelly E. Manning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly E. Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Manning. The network helps show where Kelly E. Manning may publish in the future.

Co-authorship network of co-authors of Kelly E. Manning

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly E. Manning. A scholar is included among the top collaborators of Kelly E. Manning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly E. Manning. Kelly E. Manning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Moreno, Alberto, Kelly E. Manning, Ajay K. Nooka, et al.. (2024). Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity. npj Vaccines. 9(1). 201–201.
2.
Nyhoff, Lindsay E., Veronika I. Zarnitsyna, Alberto Moreno, et al.. (2023). Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults. iScience. 26(10). 107967–107967. 11 indexed citations
3.
Mantus, Grace, Lindsay E. Nyhoff, Veronika I. Zarnitsyna, et al.. (2022). Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination. Cell Reports Medicine. 3(4). 100603–100603. 25 indexed citations
4.
Gupta, Sneh Lata, Grace Mantus, Kelly E. Manning, et al.. (2022). Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults. Journal of Virology. 96(17). e0058222–e0058222. 15 indexed citations
5.
6.
Gupta, Sneh Lata, Grace Mantus, Kelly E. Manning, et al.. (2022). Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses Against the SARS-CoV-2 Omicron Variant in Adolescents and Adults. SSRN Electronic Journal. 3 indexed citations
7.
Manning, Kelly E., et al.. (2021). Feasibility of Social Media Recruitment for Orofacial Cleft Genetic Research. The Cleft Palate-Craniofacial Journal. 59(6). 701–707. 1 indexed citations
8.
Lomashvili, Koba A., Kelly E. Manning, M. Neale Weitzmann, et al.. (2016). Persistence of Vascular Calcification after Reversal of Uremia. American Journal Of Pathology. 187(2). 332–338. 10 indexed citations
9.
Beltrami, Elise M., Daniel Singer, Kelly E. Manning, et al.. (2000). Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. American Journal of Infection Control. 28(4). 282–285. 33 indexed citations
10.
Jochimsen, Elise M., Kelly E. Manning, Sally Young, et al.. (1999). Control of Vancomycin-Resistant Enterococci at a Community Hospital: Efficacy of Patient and Staff Cohorting. Infection Control and Hospital Epidemiology. 20(2). 106–109. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orna Schwartz Breakdown of academic impact, for papers by Samia Arshad Breakdown of academic impact, for papers by Femke Mollema Breakdown of academic impact, for papers by Laura Campogiani Breakdown of academic impact, for papers by Zeynep Türe Breakdown of academic impact, for papers by Akitoshi Ueno Breakdown of academic impact, for papers by Carmen Gómez-González Breakdown of academic impact, for papers by E. Ruiz de Gopegui Breakdown of academic impact, for papers by E.P.M. van Elzakker Breakdown of academic impact, for papers by Rafaël Mahieu
Rankless by CCL
2026